Although several studies proved a causal relationship between the PNPLA3 I148M variant and MASLD development and particularly fibrosis, the pathological mechanisms promoting this phenotype have not yet been fully clarified. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.